📣 How many healthy people in a high-income, low-resistance country will be #ESBL carriers? In this prospective cohort of >700 adults with no at-risk travel history, whole genome sequencing showed 5% prevalence. It was all #Ecoli.
#IDSky #clinmicro #MedSky #OA
www.cmi-comms.org/article/S295...
#IDSky #clinmicro #MedSky #OA
www.cmi-comms.org/article/S295...
Carriage of extended-spectrum β-lactamase–producing Enterobacterales among healthy adults: a cohort study in Finland
Despite increasing antimicrobial resistance (AMR) in clinical samples in high-income
countries, data on healthy community dwellers remains limited. We explored the prevalence
and types of extended-spe...
www.cmi-comms.org
November 13, 2025 at 7:27 PM
Thirty-Day Readmission Risk Among Adults Hospitalized for Heart Failure or Acute Myocardial Infarction with and without HIV
✅ Just Accepted
🔗 https://bit.ly/4nNxIa1
✅ Just Accepted
🔗 https://bit.ly/4nNxIa1
November 13, 2025 at 7:25 PM
FDA approves new IV antibiotic for complicated urinary tract infections
The intravenous formulation of fosfomycin has a novel mechanism of action and no known cross-resistance to other antibiotic classes.
The intravenous formulation of fosfomycin has a novel mechanism of action and no known cross-resistance to other antibiotic classes.
FDA approves new IV antibiotic for complicated urinary tract infections
The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic classes.
www.cidrap.umn.edu
November 6, 2025 at 4:49 PM
In a follow up study presenting 96 week results, cabotegravir and rilpivirine long-acting therapy is still non-inferior to oral therapy for HIV, had acceptable safety profiles and resulted in durable virologic suppression. https://www.nature.com/articles/s41591-025-04041-7
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial - Nature Medicine
In this follow-up study presenting results at 96 weeks, cabotegravir and rilpivirine long-acting therapy remained noninferior to oral therapy, had acceptable safety and tolerability profiles, and resulted in durable virologic suppression, further supporting its consideration for African treatment programs.
www.nature.com
November 6, 2025 at 4:48 PM
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3X3UaAs
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3X3UaAs
October 31, 2025 at 2:58 PM
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ws4x0Q
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ws4x0Q
October 31, 2025 at 2:57 PM
C difficile deaths more common among Whites, people in large urban areas
White Americans accounted for 84% of the 216,311 C difficile-associated deaths reported from 1999 through 2023, researchers reported at IDWeek 2025.
www.cidrap.umn.edu/c...
White Americans accounted for 84% of the 216,311 C difficile-associated deaths reported from 1999 through 2023, researchers reported at IDWeek 2025.
www.cidrap.umn.edu/c...
October 22, 2025 at 12:48 PM
Do Aminopenicillins Have a Role in Treating Ampicillin-Resistant Enterococcus UTIs?
✅ Just Accepted
#IDSky
🔗 https://bit.ly/46QolRz
✅ Just Accepted
#IDSky
🔗 https://bit.ly/46QolRz
October 22, 2025 at 12:47 PM
Our new issue is out featuring a surveillance paper to provide estimates on healthcare-associated infections #HAI prevalence and #antibiotic use in Swiss long-term care facilities
Take a look 🗞️ bit.ly/EUS3038
#IDSky #EpiSky #MedSky #AMR 🛟🧪⚕️🦠
Take a look 🗞️ bit.ly/EUS3038
#IDSky #EpiSky #MedSky #AMR 🛟🧪⚕️🦠
September 27, 2025 at 11:20 PM
Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital
In a resource-limited setting at Siriraj Hospital, a cluster-randomized trial in six medical wards compared enhanced CRE prevention—including education, al
bit.ly
September 27, 2025 at 11:19 PM
Costs of four months of rifampin versus two months of double-dose rifampin for tuberculosis infection: post-hoc analysis of a phase 2b randomized trial
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IwFxCf
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3IwFxCf
September 19, 2025 at 3:21 PM
SLC22A1 Resists Hepatitis B Virus by Activating the JAK/STAT Pathway and Predicts the Effect of Pegylated Interferon α–Based Therapy on Chronic Hepatitis B
#IDSky
#IDSky
SLC22A1 Resists Hepatitis B Virus by Activating the JAK/STAT Pathway and Predicts the Effect of Pegylated Interferon α–Based Therapy on Chronic Hepatitis B
The association between SLC22A1 and chronic hepatitis B (CHB) was elucidated. Hepatitis B virus (HBV) down-regulated SLC22A1, which in turn suppressed HBV
bit.ly
September 19, 2025 at 3:20 PM
Azelastine nasal spray showed promise in a phase 2 trial - patients using it had fewer SARS-CoV-2 infections (2.2% vs 6.7%), longer time to infection, and reduced symptomatic cases. Larger studies are needed to confirm. #COVID19 #IDsky #MEDsky
More details: www.contagionlive.com/view/azelast...
More details: www.contagionlive.com/view/azelast...
Azelastine Nasal Spray Reduces SARS-CoV-2 Infections in Phase 2 Trial
Single-center randomized trial shows lower infection rates and extended time to SARS-CoV-2 infection, though larger studies are needed to confirm findings.
www.contagionlive.com
September 6, 2025 at 1:09 PM
Three Year Outcomes after Programmatic Transitioning to Dolutegravir in the Context of Severe Civil Unrest in Haiti
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Three Year Outcomes after Programmatic Transitioning to Dolutegravir in the Context of Severe Civil Unrest in Haiti
Tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) is widely prescribed in low and middle-income countries.
bit.ly
September 6, 2025 at 1:05 PM
Reposted by Becca <3
Three Year Outcomes after Programmatic Transitioning to Dolutegravir in the Context of Severe Civil Unrest in Haiti
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Three Year Outcomes after Programmatic Transitioning to Dolutegravir in the Context of Severe Civil Unrest in Haiti
Tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) is widely prescribed in low and middle-income countries.
bit.ly
September 5, 2025 at 8:20 PM
Three Year Outcomes after Programmatic Transitioning to Dolutegravir in the Context of Severe Civil Unrest in Haiti
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Age-Dependent Assortativeness in Herpes Simplex Virus Type 1 Oral Transmission in the United States: A Mathematical Modeling Analysis
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Age-Dependent Assortativeness in Herpes Simplex Virus Type 1 Oral Transmission in the United States: A Mathematical Modeling Analysis
Herpes simplex virus type 1 (HSV-1) is a highly infectious, globally prevalent lifelong infection.
doi.org
April 1, 2025 at 9:00 PM
The Impact of COVID-19 Non-Pharmaceutical Interventions on Incidence of Acute Gastroenteritis and Acute Respiratory Infections Among US Military and Dependents
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
The Impact of COVID-19 Non-Pharmaceutical Interventions on Incidence of Acute Gastroenteritis and Acute Respiratory Infections Among US Military and Dependents
Non-pharmaceutical interventions (NPIs) for COVID-19 reduced many viral diseases aside from SARS-CoV-2, but their impact on the US military or beneficiary population have not been assessed.
doi.org
April 1, 2025 at 8:59 PM
IL-8 as a causal link between aging and impaired influenza antibody responses in older adults
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
IL-8 as a causal link between aging and impaired influenza antibody responses in older adults
Antibody responses to MF59-adjuvanted (MF59Flu) and high-dose (HDFlu) influenza vaccines have been well-characterized in older adults, yet corresponding cellular immune response data remain limited.
doi.org
March 24, 2025 at 4:24 PM
Comparison of COVID-19 vs non-COVID-19 patients without hematological malignancies treated for invasive pulmonary aspergillosis: a 5-year retrospective cohort study with propensity-based adjustment
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Comparison of COVID-19 vs non-COVID-19 patients without hematological malignancies treated for invasive pulmonary aspergillosis: a 5-year retrospective cohort study with propensity-based adjustment
Our aim was to compare epidemiological, clinical and treatment characteristics, and outcomes between patients diagnosed with COVID-19-associated pulmonary aspergillosis (CAPA) and Putative Invasive Pulmonary Aspergillosis (PIPA), without hematological malignancies.
doi.org
March 24, 2025 at 4:23 PM
Validation of the proposed definition for complicated coagulase negative staphylococcal bacteremia
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Validation of the proposed definition for complicated coagulase negative staphylococcal bacteremia
A new definition for complicated coagulase-negative staphylococcal (CoNS) bacteremia was recently proposed. The aim of this study was to identify predictors of mortality in patients with CoNS bacteremia and evaluate the proposed definition of complicated bacteremia.
doi.org
March 18, 2025 at 3:48 PM
⭐ NEW PUBLICATION ⭐
The global burden of human metapneumovirus-associated acute respiratory infections in older adults: a systematic review and meta-analysis
#UsherInstitute
Read more ➡️ pubmed.ncbi.nlm.nih.gov/39954700/
The global burden of human metapneumovirus-associated acute respiratory infections in older adults: a systematic review and meta-analysis
#UsherInstitute
Read more ➡️ pubmed.ncbi.nlm.nih.gov/39954700/
March 18, 2025 at 3:48 PM
Protective Effects of Recombinant Zoster Vaccine and Antiviral Therapy Against Cardiovascular Disease Following Herpes Zoster Infection
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Protective Effects of Recombinant Zoster Vaccine and Antiviral Therapy Against Cardiovascular Disease Following Herpes Zoster Infection
Herpes zoster (HZ) is associated with a higher risk of cardiovascular events, but the effect of the recombinant zoster vaccine (RZV) on this risk, alone or in combination with antiviral treatment, remains uncertain.
buff.ly
March 10, 2025 at 3:58 PM
Estimating the serotype-specific association between the concentration of vaccine-induced serum antibodies and protection against pneumococcal colonization
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Estimating the serotype-specific association between the concentration of vaccine-induced serum antibodies and protection against pneumococcal colonization
Pneumococcal conjugate vaccines (PCVs) offer indirect protection by reducing pneumococcal colonization in the vaccinated children and thus transmission.
buff.ly
March 10, 2025 at 3:57 PM
The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis
The treatment of gram-negative bacterial infections exhibiting resistance to all traditional β-lactam and fluoroquinolone agents (i.e., difficult-to-treat resistance [DTR]) poses challenges due to the limited numbers of active antibiotic agents, in addition to limited data on safety and efficacy.
buff.ly
February 25, 2025 at 12:38 AM
Study finds increase in macrolide-resistant Mycoplasma pneumoniae in children
Amid a post-pandemic increase in pediatric M pneumoniae cases, researchers at an Ohio children's hospitals found rising rates of macrolide-resistance mutations.
www.cidrap.umn.edu/a...
Amid a post-pandemic increase in pediatric M pneumoniae cases, researchers at an Ohio children's hospitals found rising rates of macrolide-resistance mutations.
www.cidrap.umn.edu/a...
February 25, 2025 at 12:38 AM